Bio Pharma Dive
JANUARY 7, 2025
Denali’s medicine and a similar one from Calico Life Sciences and AbbVie were not much different than a placebo, bringing the tally of failed drugs in the innovative “Healey platform trial” to seven.
XTalks
JANUARY 7, 2025
In a major leap forward for trauma care, Humacyte has received full approval from the US Food and Drug Administration (FDA) for Symvess, a first-of-its-kind bioengineered human tissue designed to repair extremity arterial injuries. Dr. Rishi Kundi, a clinical investigator at the University of Maryland Medical System, believes Symvess holds the potential to transform vascular trauma care by overcoming longstanding challenges like infection control and graft failure that have plagued traditional r
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
JANUARY 7, 2025
The three-year partnership is another example of Vertex’s interest in improving on Casgevy, its CRISPR medicine for sickle cell and beta thalassemia.
AuroBlog - Aurous Healthcare Clinical Trials blog
JANUARY 7, 2025
Still from Breath of the Wild. (Nintendo) Many modern video games fall into the open-world category, giving players vast, detailed worlds to explore and a new study shows these expansive digital playgrounds have benefits for our mental health.
Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Bio Pharma Dive
JANUARY 7, 2025
The startup, which has already raised more than half a billion dollars, released Phase 2 results that could position its drug as a future threat to weight loss medicines from Novo Nordisk and Eli Lilly.
XTalks
JANUARY 7, 2025
The medical device and medtech industry has undergone significant mergers and acquisitions over the past decade. These strategic deals have reshaped the competitive landscape, spurred innovation and enabled companies to diversify their product offerings, expand into new markets and enhance operational efficiencies. This list highlights the top 10 largest mergers and acquisitions among companies in the medical device, medtech and diagnostics sector from the past decade.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Pharmaceutical Technology
JANUARY 7, 2025
Variant has entered a multi-year research partnership with Novo Nordisk to identify new targets to treat metabolic conditions.
Pharma Times
JANUARY 7, 2025
OAV101 IT expands potential for type II SMA patients
Pharmaceutical Technology
JANUARY 7, 2025
The FDA has accepted for filing and priority review Sentynl Therapeutics CUTX-101 NDA for the treatment of Menkes disease.
Pharma Times
JANUARY 7, 2025
M-Trust set to improve product safety and counterfeiting solutions
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharmaceutical Technology
JANUARY 7, 2025
The transaction is expected to close in the first half of 2025, subject to the satisfaction of customary closing conditions.
pharmaphorum
JANUARY 7, 2025
The life sciences industry is in a position to help humanity, perhaps more than ever, with the introduction of generative AI (GenAI).
Pharmaceutical Technology
JANUARY 7, 2025
Candid plans to conduct first-in-human studies in 2026 as it continues its T-cell engager deal drive.
pharmaphorum
JANUARY 7, 2025
The FDA has placed the credibility of AI's 'context of use' in pharma development at the heart of its first guidance in this area
Pharmaceutical Technology
JANUARY 7, 2025
The FDA has granted ODD to Tempest's amezalpat (TPST-1120), for individuals with hepatocellular carcinoma (HCC).
pharmaphorum
JANUARY 7, 2025
Verona Pharma's plans to transform COPD treatment with recently approved Ohtuvayre look like they are on course, given early sales figures.
Pharmaceutical Technology
JANUARY 7, 2025
Acelyrin plans to initiate two Phase III studies this quarter, which will enrol up to 350 patients with thyroid eye disease (TED).
pharmaphorum
JANUARY 7, 2025
A man in Louisiana has become the first recorded fatality in the US attributed to the H5N1 strain of bird flu.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Pharmaceutical Technology
JANUARY 7, 2025
The landscape of pandemic response has been transformed, with new standards being set for clinical excellence. A new report looks at emerging therapies, trial insights, and the innovations shaping the future of global healthcare.
pharmaphorum
JANUARY 7, 2025
GSK has claimed its second breakthrough designation from the FDA for B7-H3-targeted ADC, this time in osteosarcoma.
Outsourcing Pharma
JANUARY 7, 2025
Denali Therapeutics' DNL343 fails to slow ALS progression in phase 2/3 trial but shows safety and offers insights for future analysis.
pharmaphorum
JANUARY 7, 2025
Large pharma companies now generally have good awareness of the value of IDMP-based product data standardisation as part of wider process digitalisation ambitions.
Pharmaceutical Commerce
JANUARY 7, 2025
In the second part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Jon Kostas, executive director, Association for Prescription Psychedelics (APP), explains why this resource is an asset, specifically for research in the psychedelic space.
pharmaphorum
JANUARY 7, 2025
3 ways AI and patient-centred support can improve medication adherence Nicole.
ACRP blog
JANUARY 7, 2025
As Christina Brennan, MD, MBA, CCRC, begins her volunteer duties as the 2025 Chair of the Association Board of Trustees (ABoT) for ACRP, she took time to answer some questions about her experience in the clinical research enterprise, some of the challenges and opportunities facing it, and how ACRP can be of service to its members and stakeholders. Q: Can you give us the quick highlights along your career roadmap to serving as the 2025 Chair of the ABoT that you believe will help you achieve your
Pharma Marketing Network
JANUARY 7, 2025
Table of Contents Sr# Headings 1 Introduction: Why Pharma Marketing Matters 2 Digital Dominance in Pharma Marketing 3 Personalization: The Future of Engagement 4 Regulatory Updates Impacting Pharma Ads Introduction: Why Pharma Marketing Matters The world of pharmaceutical marketing is evolving rapidly, and staying informed is no longer optional for executives.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Pharmaceutical Commerce
JANUARY 7, 2025
The deal is expected to be finalized by the first half of this year.
Pharma Marketing Network
JANUARY 7, 2025
Table of Contents Sr# Headings 1 Introduction: The Importance of Marketing in Pharma 2 Digital Strategies Redefining Pharma Marketing 3 Building Trust Through Patient-Centric Campaigns 4 Navigating Compliance While Innovating Introduction: The Importance of Marketing in Pharma Marketing in pharma has never been more critical. In todays rapidly evolving landscape, executives must navigate a complex mix of innovation, regulation, and competition to remain relevant.
Velocity Clinical Research
JANUARY 7, 2025
Velocitys team contributed to the new Association of Clinical Research Professionals (ACRP) comprehensive whitepaper, titled ‘Responsible Oversight of Artificial Intelligence for Clinical Research Professionals.’ The development of our VISION technology has coincided with the proliferation of AI and large language models (LLMs). For recruitment purposes, these tools have improved patient-trial matching, automated outreach, and enabled the creation of more granular potential participa
Pharma Marketing Network
JANUARY 7, 2025
Table of Contents Sr# Headings 1 Introduction: Big Pharma and Public Perception 2 Transparency: The First Step to Trust 3 Humanizing Big Pharma Through Patient-Centric Marketing 4 The Role of Community and Corporate Responsibility Introduction: Big Pharma and Public Perception The term Big Pharma often stirs strong emotions, conjuring both respect for its life-saving innovations and skepticism over perceived corporate motives.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Expert insights. Personalized for you.
328 
Let's personalize your content